Acute childhood malnutrition (wasting and/or nutritional oedema) Nutritional, Metabolic, Endocrine
Conditions
Interventions
This is a non-blinded, prospective, longitudinal, cluster-randomized, controlled trial, using villages served by a single Family Health Worker (FHW
Community Health Worker) as the unit of randomisation.
The Trial Treatment Package (iCCM+) will be the provision of treatment for uncomplicated acute malnutrition, in children 6 months to 5 years, by
died
defaulted
non-progressed
non-recovered
or transferred to a treatment site outside the trial area.
Each study cluster will be comprised of a village (Somali: tuulo) in which an FHW has previously been appointed and is currently providi
Sponsors
University College London
Eligibility
Sex/Gender
All
Age
0.6 Months to 59 Months
Inclusion criteria
Inclusion criteria: 1. Children aged 6-59 months 2. Living in households within the participating clusters (villages)
Exclusion criteria
Exclusion criteria: 1. Children that are absent from their households during data collection 2. Children that are in hospital for a reason other than malnutrition 3. Children that cannot be measured due to an impairment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Treatment coverage for moderate acute malnutrition (diagnosed using mid-upper arm circumference (MUAC)), defined as being currently enrolled in a village-level or facility treatment programme, measured using study records on the day of the data collection 2. Treatment coverage for severe acute malnutrition (diagnosed using MUAC and/or nutritional oedema), defined as being currently enrolled in a village-level or facility treatment programme, measured using study records on the day of the data collection | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Number of cases of acute malnutrition diagnosed by FHW measured using health worker record books over the study period 2. Recovery (Number of cases successfully discharged by the FHW or health facility as recovered, divided by total discharges multiplied by 100) measured using household follow-up interviews throughout the trial 3. Non-recovery proportion number of non-responses and non-progressions, divided by total discharges multiplied by 100) measured using household follow-up interviews throughout the trial 4. Default proportion (Number of defaulters divided by total discharges multiplied by 100) measured using household follow-up interviews throughout the trial 5. Relapse rate (proportion of cured children who become malnourished within 6 months of discharge) measured using household follow-up interviews throughout the trial 6. Death rate (Number of beneficiaries who died whilst registered in the programme, divided by total discharges multiplied by 100) measured using household follow-up interviews throughout the trial 7. Average length of stay in a treatment programme (days) measured using household follow-up interviews throughout the trial. Length of stay is the number of days elapsed between admission and discharge. Average Length of Stay = Sum of Individual Length of stay (recovered beneficiaries) in days / Number of recovered beneficiaries. 8. Average gain in MUAC (mm/week) measured using household follow-up interviews throughout the trial 9. Cost per child treated (admitted) measured using study and programme implementation cost records at the end of the study 10. Cost per child cured/recovered measured using study and programme implementation cost records at the end of the study 11. Prevalence of GAM at baseline and endline measured during baseline and endline surveys 12. Number of diagnoses and diagnostic rate (diagnoses per 1,000 children/month) for each condition (ARI, malaria, diarrhoea, and acute malnutrition) measured using health worker r | — |
Countries
Somalia
Contacts
Public ContactAndrew Seal
Outcome results
None listed